4.5 Review

The Solid State Landscape of the Sildenafil Drug

Journal

JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 111, Issue 4, Pages 1104-1109

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.xphs.2021.08.019

Keywords

-

Ask authors/readers for more resources

Sildenafil, a drug used for the treatment of erectile dysfunction, is one of the most prescribed drugs for sexual performance in the western world. Crystallographers have discovered and characterized multiple forms of sildenafil crystals, including polymorphs, hydrates, solvates, salts, and cocrystals, making it one of the most diverse multicomponent crystal drugs in the pharmaceutical sciences field.
Sildenafil, the active ingredient of the drug developed by Pfizer for the treatment of erectile dysfunction was firstly synthesized in 1989 in the United Kingdom and since then it has become one of the most prescribed drugs for sexual performance in the western world with more than 2.7 million prescriptions in the US in 2021. Since its discovery, this drug compound has attracted the interest of formulators and crystallographers, with a high number of crystal forms of sildenafil being found and characterized, including polymorphs, hydrates, solvates, salts and cocrystals, converting it in one of the most promiscuous multicomponent crystal former drugs in the pharmaceutical sciences arena. In this minireview, the polymorph, pseudopolymorph and multicomponent solid forms landscape of sildenafil is presented through a comprehensive compilation of their 42 solid forms reported in literature. (C)& nbsp;2021 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available